These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33204291)

  • 1. Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19.
    Niu W; Wu F; Cui H; Cao W; Chao Y; Wu Z; Fan M; Liang C
    Evid Based Complement Alternat Med; 2020; 2020():7493281. PubMed ID: 33204291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6.
    Niu WH; Wu F; Cao WY; Wu ZG; Chao YC; Liang C
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33146673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.
    Huang K; Zhang P; Zhang Z; Youn JY; Wang C; Zhang H; Cai H
    Pharmacol Ther; 2021 Sep; 225():107843. PubMed ID: 33811957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches.
    Jia K; Li Y; Liu T; Gu X; Li X
    Chin Herb Med; 2023 Apr; 15(2):157-168. PubMed ID: 37220535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal medicines exhibit a high affinity for ACE2 in treating COVID-19.
    Zhang B; Qi F
    Biosci Trends; 2023 Mar; 17(1):14-20. PubMed ID: 36596560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Role of Gut Microbiota in Traditional Chinese Medicine against COVID-19.
    Zhang Q; Yue S; Wang W; Chen Y; Zhao C; Song Y; Yan D; Zhang L; Tang Y
    Am J Chin Med; 2021; 49(4):785-803. PubMed ID: 33853498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of
    Yan H; Zou Y; Zou C
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):616-623. PubMed ID: 32897211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Traditional Chinese Medicine in Treating COVID-19: Clinical Evidence from China.
    Xing D; Liu Z
    Aging Dis; 2021 Dec; 12(8):1850-1856. PubMed ID: 34881072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bibliometric analysis of research related Chinese Medicine in the prevention and treatment of corona virus disease 2019.
    Dayuan Z; Lan L; Luhua X; Huanjie L; Dahao C; Yumiao L; Dingxiang L; Yihui D
    Heliyon; 2022 Nov; 8(11):e11120. PubMed ID: 36278116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rationality of Asari Radix et Rhizoma in Qingfei Paidu Decoction based on literature analysis].
    Qin ZN; Wang MX; Shi NN; Wang YP; Zhai HQ
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1515-1520. PubMed ID: 32489028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19.
    Xia QD; Xun Y; Lu JL; Lu YC; Yang YY; Zhou P; Hu J; Li C; Wang SG
    Cell Prolif; 2020 Dec; 53(12):e12949. PubMed ID: 33140889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composition, Clinical Efficiency, and Mechanism of NHC-Approved "Three Chinese Medicines and Three Chinese Recipes" for COVID-19 Treatment.
    Xia KY; Zhao Z; Shah T; Wang JY; Baloch Z
    Front Pharmacol; 2021; 12():781090. PubMed ID: 35185537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma.
    Qi F; Tang W
    Biosci Trends; 2021 Sep; 15(4):201-204. PubMed ID: 34193750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine.
    Ye L; Fan S; Zhao P; Wu C; Liu M; Hu S; Wang P; Wang H; Bi H
    Acta Pharm Sin B; 2023 Jun; 13(9):3598-637. PubMed ID: 37360014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19.
    Yu S; Wang J; Shen H
    Ann Palliat Med; 2020 Mar; 9(2):437-446. PubMed ID: 32233641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening.
    Chen X; Wu Y; Chen C; Gu Y; Zhu C; Wang S; Chen J; Zhang L; Lv L; Zhang G; Yuan Y; Chai Y; Zhu M; Wu C
    Acta Pharm Sin B; 2021 Jan; 11(1):222-236. PubMed ID: 33072499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19.
    Li L; Wang X; Guo X; Li Y; Song Q; Li A
    Front Pharmacol; 2022; 13():1013428. PubMed ID: 36210820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering suppressive effects of Lianhua Qingwen Capsule on COVID-19 and synergistic effects of its major botanical drug pairs.
    Chen Y; Zhang C; Wang N; Feng Y
    Chin J Nat Med; 2023 May; 21(5):383-400. PubMed ID: 37245876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China.
    Zhuang W; Fan Z; Chu Y; Wang H; Yang Y; Wu L; Sun N; Sun G; Shen Y; Lin X; Guo G; Xi S
    Front Pharmacol; 2020; 11():1066. PubMed ID: 32848729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China.
    Luo E; Zhang D; Luo H; Liu B; Zhao K; Zhao Y; Bian Y; Wang Y
    Chin Med; 2020; 15():34. PubMed ID: 32308732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.